awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37742180-A640A1B3-2FDA-4820-A53D-9DEADB47014B
Q37742180-A640A1B3-2FDA-4820-A53D-9DEADB47014B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37742180-A640A1B3-2FDA-4820-A53D-9DEADB47014B
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG
P2860
Q37742180-A640A1B3-2FDA-4820-A53D-9DEADB47014B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37742180-A640A1B3-2FDA-4820-A53D-9DEADB47014B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bef52b4e7e6bb3d48ee30dc3f7268a6236b74667
P2860
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.